sodium alginate
UkraineDrugs containing this active substance
-
The drug is used to treat symptoms of gastroesophageal reflux accompanied by acid regurgitation, heartburn, and digestive disturbances (e.g., after meals).
Form: suspension, oral
Active substance Dosage sodium alginate 500 mg/10 ml sodium bicarbonate 213 mg/10 ml calcium carbonate 325 mg/10 ml ATC: A02BX
Manufacturer: Ternofarm LLC
-
The drug is used to treat the symptoms of gastroesophageal reflux disease, including heartburn, acid regurgitation, and indigestion associated with reflux. It can also be used during pregnancy.
Form: tablets, chewable
Active substance Dosage sodium alginate 250 mg sodium bicarbonate 133.5 mg calcium carbonate 80 mg ATC: A02BX13
Manufacturer: LLC "Pharmaceutical Company "Zdorovya"
-
The drug is used for the symptomatic treatment of heartburn and gastroesophageal reflux. It can also be used by pregnant women if necessary, following consultation with a physician.
Form: suspension, oral
Active substance Dosage sodium alginate 250 mg/5 ml sodium bicarbonate 133.5 mg/5 ml calcium carbonate 80 mg/5 ml ATC: A02BX13
Manufacturer: LLC "Pharmaceutical Company "Zdorovya"
-
The drug is used to treat symptoms of gastroesophageal reflux, such as heartburn, acid regurgitation, and indigestion (e.g., after meals). It can also be used during pregnancy.
Form: tablets, chewable
Active substance Dosage sodium alginate 250 mg sodium bicarbonate 106.5 mg calcium carbonate 187.5 mg ATC: A02BX
-
The drug is used to treat symptoms of gastroesophageal reflux, such as heartburn, acid regurgitation, and indigestion (e.g., after meals). It can also be used during pregnancy.
Form: suspension, oral
Active substance Dosage sodium alginate 500 mg sodium bicarbonate 213 mg calcium carbonate 325 mg ATC: A02BX
Manufacturer: Reckitt Benckiser Healthcare (UK) Limited
-
The drug is used to treat symptoms of gastroesophageal reflux, such as heartburn, acid regurgitation, and indigestion associated with reflux (e.g., after meals or during pregnancy), as well as reflux esophagitis.
Form: suspension, oral
Active substance Dosage sodium alginate 100 mg/ml potassium bicarbonate 20 mg/ml ATC: A02BX
Manufacturer: Reckitt Benckiser Healthcare (UK) Limited
-
The product is used for the symptomatic treatment of heartburn and gastro-oesophageal reflux, particularly in pregnant women.
Form: suspension, oral
Active substance Dosage sodium alginate 250 mg/5 ml sodium bicarbonate 133.5 mg/5 ml calcium carbonate 80 mg/5 ml ATC: A02BX13
Manufacturer: Reckitt Benckiser Healthcare (UK) Limited
-
The preparation is used to treat the symptoms of gastroesophageal reflux disease, specifically heartburn, acid regurgitation, and indigestion associated with reflux. It can also be used during pregnancy.
Form: tablets, chewable
Active substance Dosage sodium alginate 250 mg sodium bicarbonate 133.5 mg calcium carbonate 80 mg ATC: A02BX13
Manufacturer: Reckitt Benckiser Healthcare (UK) Limited
-
The drug is used to treat the symptoms of gastroesophageal reflux disease, including heartburn, acid regurgitation, and indigestion associated with reflux. It can also be used during pregnancy.
Form: tablets, chewable
Active substance Dosage sodium alginate 250 mg sodium bicarbonate 133.5 mg calcium carbonate 80 mg ATC: A02BX13
Manufacturer: Reckitt Benckiser Healthcare (UK) Limited (bulk manufacturing, packaging, release control, batch release)